Major new drugs for 2012
March 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Caprelsa, Eylea, Manjor new drugs, Xalkori, Zelboraf, avastin, inlyta
Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …
Battle against prostate cancer gains celebrity endorsement
March 9, 2012Medical Communications M&S, MS, Vader, prostate
A famous DJ and a legendary Star Wars actor have joined forces to raise awareness of prostate cancer. Star Wars …
inVentiv appoints former Quintiles man Mark Archer
March 9, 2012Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv
Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
Government touts telehealth scheme
March 9, 2012Medical Communications, Sales and Marketing NHS, king's fund, telecare, telehealth
The government has said that telehealth and telecare technology could save the NHS £1.2 billion over the next five years. …
New website launched to help people with psoriasis
March 9, 2012Medical Communications 360. PM soc, Twitter, psoriasis
A new online resource for patients with psoriasis has been set up to help them understand and manage their disease. …
NICE recommends Victrelis in speedy review
March 9, 2012Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis
NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review. In its final …
Aurora bolsters senior team with new director
March 8, 2012Business Services, Medical Communications, Sales and Marketing Aurora, LoweFusion, Pan
Aurora has appointed Rachel Terry as its new director.Terry was previously director of healthcare at Burson-Marsteller until the end of …
Synthes plant cited in FDA warning letter
March 8, 2012Manufacturing and Production FDA, J&J, JJ, Synthes, manufacturing
The US FDA has sent a warning letter to surgical equipment manufacturer Synthes upbraiding it for deficiencies at a manufacturing …
Boehringer censured over Pradaxa website
March 8, 2012Medical Communications ABPI, Boehringer Ingelheim, PMCPA, Pradaxa
Boehringer Ingelheim has breached the ABPI’s Code of Conduct over the use of its Pradaxa website. Pradaxa is a …
Keep Alzheimer’s patients on Aricept for longer, study says
March 8, 2012Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil
Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
Biotec launches new operational facilities and increases temperature controlled storage
March 8, 2012Manufacturing and Production
UK based pharmaceutical services business Biotec Services International has launched a dedicated new storage and operational facility along with upgraded …
Novartis Indian patent battle nears conclusion
March 7, 2012Sales and Marketing Glivec, HIV, India, Novartis, patents
A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …
Pfizer’s virtual trial fails in recruitment drive
March 7, 2012Medical Communications Pfizer, bladder, virtual clinic, youtube
The world’s first ‘virtual’ clinic has failed to recruit patients in the US, representing a major blow to Pfizer. The …
Sandoz falls foul of ABPI Code
March 7, 2012Medical Communications, Sales and Marketing ABPI Code of Practice, Sandoz
Sandoz has been rapped over the knuckles for offering non-approved bags and bottles to patients.It was found to be offering …
Onyx appoints Luigi Costa as its new vice president of Europe
March 7, 2012Sales and Marketing Luigi Costa, Onyx
Onyx Pharmaceuticals International has appointed Luigi Costa as vice president and head of its European division. Costa will report to …
Cancer Drugs Fund should not be used across the UK
March 7, 2012Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate
The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …
NICE appoints two new directors
March 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE
The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …
Can Europe really agree to speed up pricing and reimbursement?
March 6, 2012Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement
The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …
Web-based tool for chronic diseases launched in UK
March 6, 2012Medical Communications Curavista Health, HealthCare21, MyHealthMonitor, telecare, telehealth
A new electronic tool to help patients and their doctors monitor long-term conditions has been launched in the UK. The …
Ranbaxy launches generic Lipitor in Europe
March 6, 2012Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics
Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date. The Indian …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
